Year-end Sale % OFF 
Abstract
IntroductionCorticosteroids have been considered the treatment of choice for induction of remission in patients with active Crohn's disease. However, a significant number of patients have an inadequate response or adverse events to these drugs. Therapeutic managementIn this setting, immunosuppressants, thiopurines and methotrexate, and biologic drugs, mainly anti-TNF, have achieved a long-term free steroid clinical remission. PrognosisIn addition, the early and combined use of these drugs has been associated with a better prognosis with lower rates of relapse, hospitalization and surgery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
